{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T15:05:24Z","timestamp":1768835124316,"version":"3.49.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004410","name":"T\u00fcrkiye Bilimsel ve Teknolojik Ara\u015ft\u0131rma Kurumu","doi-asserted-by":"publisher","award":["119S350"],"award-info":[{"award-number":["119S350"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.cyto.2023.156247","type":"journal-article","created":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T18:05:05Z","timestamp":1686161105000},"page":"156247","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Accelerated kynurenine pathway downregulates immune activation in patients with axial spondyloarthritis"],"prefix":"10.1016","volume":"169","author":[{"given":"Emine Feyza","family":"Yurt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cemile","family":"Bi\u00e7er","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhittin A.","family":"Serdar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sel\u00e7uk","family":"Akan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u015e\u00fckran","family":"Erten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2023.156247_b0005","doi-asserted-by":"crossref","unstructured":"J.A. Walsh, M. Magrey, Clinical Manifestations and Diagnosis of Axial Spondyloarthritis. Journal of clinical rheumatology: practical reports on rheumatic & musculoskeletal diseases, 2021. 27(8): p. e547-e560.","DOI":"10.1097\/RHU.0000000000001575"},{"issue":"1","key":"10.1016\/j.cyto.2023.156247_b0010","doi-asserted-by":"crossref","first-page":"9","DOI":"10.5114\/reum.2015.50551","article-title":"Cytokine profiles in axial spondyloarthritis","volume":"53","author":"Madej","year":"2015","journal-title":"Reumatologia"},{"issue":"3","key":"10.1016\/j.cyto.2023.156247_b0015","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.it.2011.10.004","article-title":"TNF superfamily in inflammatory disease: translating basic insights","volume":"33","author":"Croft","year":"2012","journal-title":"Trends Immunol"},{"key":"10.1016\/j.cyto.2023.156247_b0020","doi-asserted-by":"crossref","first-page":"4126","DOI":"10.12659\/MSM.902822","article-title":"Effect of Interferon-\u03b3 Polymorphisms on Ankylosing Spondylitis: A Case-Control Study","volume":"23","author":"Xu","year":"2017","journal-title":"Med. Sci. Monitor: Int. Med. J. Exp. Clin. Res."},{"issue":"7","key":"10.1016\/j.cyto.2023.156247_b0025","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nrrheum.2015.53","article-title":"The IL-23-IL-17 axis in inflammatory arthritis","volume":"11","author":"Lubberts","year":"2015","journal-title":"Nat. Rev. Rheumatol."},{"issue":"5","key":"10.1016\/j.cyto.2023.156247_b0030","first-page":"828","article-title":"Association between Th-17 cytokine profile and clinical features in patients with spondyloarthritis","volume":"29","author":"Romero-Sanchez","year":"2011","journal-title":"Clin. Exp. Rheumatol."},{"issue":"2","key":"10.1016\/j.cyto.2023.156247_b0035","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/14397595.2020.1830512","article-title":"Non-radiographic axial spondyloarthritis","volume":"31","author":"Kameda","year":"2021","journal-title":"Mod. Rheumatol."},{"issue":"12","key":"10.1016\/j.cyto.2023.156247_b0040","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1002\/art.30600","article-title":"Interleukin-23: A central cytokine in the pathogenesis of spondylarthritis","volume":"63","author":"Gaston","year":"2011","journal-title":"Arthritis Rheumatism"},{"issue":"1\u20132","key":"10.1016\/j.cyto.2023.156247_b0045","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.cca.2005.06.013","article-title":"Monitoring tryptophan metabolism in chronic immune activation","volume":"364","author":"Schr\u00f6cksnadel","year":"2006","journal-title":"Clin. Chim. Acta"},{"issue":"3","key":"10.1016\/j.cyto.2023.156247_b0050","doi-asserted-by":"crossref","DOI":"10.14440\/jbm.2017.182","article-title":"A mass spectrometric method for quantification of tryptophan-derived uremic solutes in human serum","volume":"4","author":"Zhang","year":"2017","journal-title":"J. Biol. Methods"},{"key":"10.1016\/j.cyto.2023.156247_b0055","doi-asserted-by":"crossref","unstructured":"A.A. Badawy, Kynurenine Pathway of Tryptophan Metabolism: Regulatory and Functional Aspects, Int. J. Tryptophan Res., 2017. 10: p. 1178646917691938.","DOI":"10.1177\/1178646917691938"},{"issue":"2","key":"10.1016\/j.cyto.2023.156247_b0060","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000213565","article-title":"Cytokine changes and tryptophan metabolites in medication-na\u00efve and medication-free schizophrenic patients","volume":"59","author":"Kim","year":"2009","journal-title":"Neuropsychobiology"},{"issue":"3","key":"10.1016\/j.cyto.2023.156247_b0065","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3390\/vaccines3030703","article-title":"The Role of Indoleamine 2, 3-Dioxygenase in Immune Suppression and Autoimmunity","volume":"3","author":"Mbongue","year":"2015","journal-title":"Vaccines"},{"issue":"4","key":"10.1016\/j.cyto.2023.156247_b0070","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ejr.2022.07.005","article-title":"Clinical significance of plasma tryptophan, kynurenine, and kynurenine\/tryptophan ratio in rheumatoid arthritis patients","volume":"44","author":"Kor","year":"2022","journal-title":"Egypt. Rheumatol."},{"issue":"8","key":"10.1016\/j.cyto.2023.156247_b0075","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1182\/blood-2006-07-034785","article-title":"HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells","volume":"109","author":"Boasso","year":"2006","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.cyto.2023.156247_b0080","doi-asserted-by":"crossref","first-page":"5484","DOI":"10.1128\/JVI.00171-07","article-title":"Epstein-Barr virus (EBV)-infected monocytes facilitate dissemination of EBV within the oral mucosal epithelium","volume":"81","author":"Tugizov","year":"2007","journal-title":"J. Virol."},{"issue":"21","key":"10.1016\/j.cyto.2023.156247_b0085","doi-asserted-by":"crossref","first-page":"5435","DOI":"10.1158\/0008-5472.CAN-12-0569","article-title":"Tryptophan catabolism in cancer: beyond IDO and tryptophan depletion","volume":"72","author":"Platten","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.cyto.2023.156247_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ensci.2020.100270","article-title":"Kynurenine pathway in Parkinson's disease\u2014An update","volume":"21","author":"Venkatesan","year":"2020","journal-title":"eNeurologicalSci"},{"key":"10.1016\/j.cyto.2023.156247_b0095","doi-asserted-by":"crossref","first-page":"9484217","DOI":"10.1155\/2022\/9484217","article-title":"Kynurenine Pathway Metabolites as Biomarkers in Alzheimer\u2019s Disease","volume":"2022","author":"Liang","year":"2022","journal-title":"Disease Markers"},{"issue":"1","key":"10.1016\/j.cyto.2023.156247_b0100","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1139\/jpn.0402","article-title":"The role of indoleamine 2,3-dioxygenase (IDO) in the pathophysiology of interferon-alpha-induced depression","volume":"29","author":"Wichers","year":"2004","journal-title":"J. Psychiatry Neurosci.: JPN"},{"issue":"1","key":"10.1016\/j.cyto.2023.156247_b0105","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/s41398-021-01688-x","article-title":"Associations between expression of indoleamine 2, 3-dioxygenase enzyme and inflammatory cytokines in patients with first-episode drug-naive Schizophrenia","volume":"11","author":"Zhang","year":"2021","journal-title":"Translational Psychiatry"},{"issue":"10","key":"10.1016\/j.cyto.2023.156247_b0110","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/2624","article-title":"Much IDO about pregnancy","volume":"4","author":"Bonney","year":"1998","journal-title":"Nature Medicine"},{"issue":"Suppl 1","key":"10.1016\/j.cyto.2023.156247_b0115","first-page":"67","article-title":"Exploitation of the IDO Pathway in the Therapy of Rheumatoid Arthritis","volume":"6","author":"Williams","year":"2013","journal-title":"Int. J. Tryptophan Res."},{"issue":"2","key":"10.1016\/j.cyto.2023.156247_b0120","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2249.2007.03480.x","article-title":"Indoleamine 2,3-dioxygenase activity is increased in patients with systemic lupus erythematosus and predicts disease activation in the sunny season","volume":"150","author":"Pertovaara","year":"2007","journal-title":"Clin. Exp. Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2023.156247_b0125","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/labmed\/lmac084","article-title":"Elevated Kynurenine Levels in Patients with Primary Sj\u00f6gren's Syndrome","volume":"54","author":"Apayd\u0131n","year":"2023","journal-title":"Lab. Med."},{"issue":"1","key":"10.1016\/j.cyto.2023.156247_b0130","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s13167-010-0009-2","article-title":"The potential role of indoleamine 2,3 dioxygenase (IDO) as a predictive and therapeutic target for diabetes treatment: a mythical truth","volume":"1","author":"Baban","year":"2010","journal-title":"EPMA J."},{"issue":"1\u20132","key":"10.1016\/j.cyto.2023.156247_b0135","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0165-0378(02)00040-2","article-title":"Indoleamine 2,3-dioxygenase, immunosuppression and pregnancy","volume":"57","author":"Mellor","year":"2002","journal-title":"J. Reprod. Immunol."},{"issue":"5","key":"10.1016\/j.cyto.2023.156247_b0140","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.immuni.2005.03.013","article-title":"GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase","volume":"22","author":"Munn","year":"2005","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.cyto.2023.156247_b0145","doi-asserted-by":"crossref","first-page":"e0130715","DOI":"10.1371\/journal.pone.0130715","article-title":"Indoleamine 2,3 Dioxygenase (IDO) Expression and Activity in Relapsing-Remitting Multiple Sclerosis","volume":"10","author":"Mancuso","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.cyto.2023.156247_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108018","article-title":"Altered kynurenine pathway metabolism in patients with ankylosing spondylitis","volume":"99","author":"Eryavuz Onmaz","year":"2021","journal-title":"Int. Immunopharmacol."},{"issue":"02","key":"10.1016\/j.cyto.2023.156247_b0155","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/rai2.12020","article-title":"Depression in patients with ankylosing spondylitis","volume":"02","author":"Ma","year":"2022","journal-title":"Rheumatol. Autoimmunity"},{"issue":"12","key":"10.1016\/j.cyto.2023.156247_b0160","first-page":"2286","article-title":"A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index","volume":"21","author":"Garrett","year":"1994","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.cyto.2023.156247_b0165","doi-asserted-by":"crossref","unstructured":"S. ero\u011flu demir, E. Aytekin, L.\u00d6zg\u00f6nenel, A. Rezvani, Y.P.Do\u011fan, N.S.\u00c7a\u011flar, et al., A Possible Correlation Among Different Disease Activity Parameters and Functional Status in Patients with Ankylosing Spondylitis, Turk. J. Rheumatol., 2013. 28: p. 117-122.","DOI":"10.5606\/tjr.2013.2916"},{"issue":"11","key":"10.1016\/j.cyto.2023.156247_b0170","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.4155\/bio.13.74","article-title":"A simple LC-MS\/MS method for determination of kynurenine and tryptophan concentrations in human plasma from HIV-infected patients","volume":"5","author":"Huang","year":"2013","journal-title":"Bioanalysis"},{"issue":"17","key":"10.1016\/j.cyto.2023.156247_b0175","doi-asserted-by":"crossref","first-page":"6401","DOI":"10.3390\/ijms21176401","article-title":"The Role of the IL-23\/IL-17 Pathway in the Pathogenesis of Spondyloarthritis","volume":"21","author":"Tsukazaki","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.cyto.2023.156247_b0180","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.it.2005.12.006","article-title":"The immunoregulatory role of IDO-producing human dendritic cells revisited","volume":"27","author":"Terness","year":"2006","journal-title":"Trends Immunol"},{"issue":"6","key":"10.1016\/j.cyto.2023.156247_b0185","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.immuni.2009.10.007","article-title":"Interferon-gamma-responsive nonhematopoietic cells regulate the immune response to Mycobacterium tuberculosis","volume":"31","author":"Desvignes","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2023.156247_b0190","doi-asserted-by":"crossref","unstructured":"A. Amobi-McCloud, R. Muthuswamy, S. Battaglia, H. Yu, T. Liu, J. Wang, et al., Indoleamine 2,3-dioxygenase upregulates PD-1 expression on ovarian tumor infiltrating CD8<sup>+<\/sup> T cells via kynurenine activation of the aryl hydrocarbon receptor. bioRxiv, 2021: p. 2021.02.18.431473.","DOI":"10.1101\/2021.02.18.431473"},{"issue":"12","key":"10.1016\/j.cyto.2023.156247_b0195","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/s41584-019-0294-7","article-title":"The IL-23\u2013IL-17 pathway as a therapeutic target in axial spondyloarthritis","volume":"15","author":"Sieper","year":"2019","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.cyto.2023.156247_b0200","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2017.01561","article-title":"The Relationships among Tryptophan, Kynurenine, Indoleamine 2,3-Dioxygenase, Depression, and Neuropsychological Performance","volume":"8","author":"Hestad","year":"2017","journal-title":"Front. Psychol."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466623001254?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466623001254?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:48:25Z","timestamp":1760910505000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466623001254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":40,"alternative-id":["S1043466623001254"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2023.156247","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Accelerated kynurenine pathway downregulates immune activation in patients with axial spondyloarthritis","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2023.156247","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"156247"}}